Schistosomiasis is a debilitating disease affecting approximately 600 million people in 74
developing countries, with 800 million, mostly children at risk. To circumvent the threat of …

Background Schistosomiasis is a major endemic disease that affects hundreds of millions
worldwide. Since the treatment and control of this parasitic disease rely on a single drug …

Despite the increasing use of protoplasts in plant biotechnology research, shoot
regeneration from protoplasts remains challenging. In this study, we investigated the factors …

Although its efficiency against all Schistosoma species, praziquantel (PZQ) shows low
efficacy against schistosomula and juvenile stages. The potential for development of …

Birds, bees, lizards, elephants, and chimpanzees all share a survival trait: They
selfmedicate. These animals eat things that make them feel better, or prevent disease, or kill …

Schistosomiasis is a neglected tropical disease that affects hundreds of millions of people
worldwide. Since the treatment of this disease currently relies on a single drug, praziquantel …

Schistosomiasis, a parasitic disease caused by trematodes of the genus Schistosoma, is the
second most prevalent parasitic disease in the world. It affects around 200 million people …

Due to the development of praziquantel (PZQ) schistosomes resistant strains, the discovery
of new antischistosomal agents is of high priority in research. This work reported the in vitro …

Blood fluke of the genus Schistosoma are the etiological agents of human schistosomiasis,
an important neglected tropical disease that afflicts over 200 million people worldwide. The …

Blood flukes of the genus Schistosoma are the causative agents of human schistosomiasis,
a debilitating disease that afflicts over 200 million people worldwide. Praziquantel is the …